Advertisement

Gender Disparities in the Quality of Cardiovascular Disease Care in Private Managed Care Plans

Published:April 24, 2007DOI:https://doi.org/10.1016/j.whi.2007.03.002

      Background

      Studies have shown that women with cardiovascular disease (CVD) are screened and treated less aggressively than men and are less likely to undergo cardiac procedures. Research in this area has primarily focused on the acute setting, and there are limited data on the ambulatory care setting, particularly among the commercially insured. To that end, the objective of this study is to determine if gender disparities in the quality of CVD care exist in commercial managed care populations.

      Methods

      Using a national sample of commercial health plans, we analyzed member-level data for 7 CVD quality indicators from the Healthcare Effectiveness Data and Information Set (HEDIS®) collected in 2005. We used hierarchical generalized linear models to estimate these HEDIS measures as a function of gender, controlling for race/ethnicity, socioeconomic status, age, and plans’ clustering effects.

      Results

      Results showed that women were less likely than men to have low-density lipoprotein (LDL) cholesterol controlled at <100 mg/dL in those who have diabetes (odds ratio [OR], 0.81; 95% confidence interval [CI], 0.76–0.86) or a history of CVD (OR, 0.72; CI 95%, 0.64–0.82). The difference between men and women in meeting the LDL control measures was 5.74% among those with diabetes (44.3% vs. 38.5%) and 8.53% among those with a history of CVD (55.1% vs. 46.6%). However, women achieved higher performance than men in controlling blood pressure (OR, 1.12; 95% CI, 1.02–1.21), where the rate of women meeting this quality indicator exceeded that of men by 1.94% (70.8% for women vs. 68.9% for men).

      Conclusions

      Gender disparities in the management and outcomes of CVD exist among patients in commercial managed care plans despite similar access to care. Poor performance in LDL control was seen in both men and women, with a lower rate of control in women suggesting the possibility of less intensive cholesterol treatment in women. The differences in patterns of care demonstrate the need for interventions tailored to address gender disparities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abrahamse A.
        • Morrison P.
        • Bolton N.
        Surname analysis for estimating local concentration of Hispanic and Asians.
        Population Research Policy & Review. 1994; 13: 383-398
        • American Heart Association (AHA)
        Heart Disease and Stroke Statistics—2004 Update. American Heart Association, Dallas2003
        • Brown D.W.
        • Giles W.H.
        • Greenlund K.J.
        • Croft J.B.
        Disparities in cholesterol screening: falling short of a national health objective.
        Preventive Medicine. 2001; 33: 517-522
        • Correa-de-Araujo R.
        • Clancy C.M.
        Catalyzing quality of care improvements for women.
        Women’s Health Issues. 2006; 16: 41-43
        • Correa-de-Araujo R.
        • McDermott K.
        • Moy E.
        Gender differences across racial and ethnic groups in the quality of care for diabetes.
        Women’s Health Issues. 2006; 16: 56-65
        • Correa-de-Araujo R.
        • Miller G.E.
        • Banthin J.S.
        • Trinh Y.
        Gender differences in drug use and expenditures in a privately insured population of older adults.
        Journal of Women’s Health. 2005; 14: 73-81
        • Correa-de-Araujo R.
        • Stevens B.
        • Moy E.
        • Nilasena D.
        • Chesley F.
        • McDermott K.
        Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities.
        Women’s Health Issues. 2006; 16: 44-55
        • Davis K.C.
        • Cogswell M.E.
        • Rothenberg S.L.
        • Koplan J.P.
        Lipid screening in a managed care population.
        Public Health Representative. 1998; 113: 346-350
        • Fremont A.M.
        • Bierman A.
        • Wickstrom S.L.
        • Bird C.E.
        • Shah M.
        • Escarce J.J.
        • et al.
        Use of geocoding in managed care settings to identify quality disparities.
        Health Affairs. 2005; 24: 516-526
        • Gardner C.D.
        • Winkleby M.A.
        • Fortmann S.P.
        Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988–1994).
        American Journal of Cardiology. 2000; 86: 299-304
        • Goff Jr., D.C.
        • Bertoni A.G.
        • Kramer H.
        • Bonds D.
        • Blumenthal R.S.
        • Tsai M.Y.
        • et al.
        Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, ethnicity, and coronary artery calcium.
        Circulation. 2006; 113: 647-656
        • Harrold L.R.
        • Lessard D.
        • Yarzebski J.
        • Gurwitz J.H.
        • Gore J.M.
        • Goldberg R.J.
        Age and sex differences in the treatment of patients with initial acute myocardial infarction: A community-wide perspective.
        Cardiology. 2003; 99: 39-46
        • Henderson J.T.
        • Weisman C.S.
        • Grason H.
        Are two doctors better than one?.
        Women’s Health Issues. 2002; 12: 138-149
        • Hendrix K.H.
        • Lackland D.T.
        • Egan B.M.
        Cardiovascular risk factor control and treatment patterns in primary care.
        Managed Care Interface. 2003; 16: 21-26
        • Hippisley-Cox J.
        • Pringle M.
        • Crown N.
        • Meal A.
        • Wynn A.
        Sex inequalities in ischaemic heart disease in general practice: cross sectional survey.
        British Medical Journal. 2001; 322: 832
        • Hollenbeak C.S.
        • Weisman C.S.
        • Rossi M.
        • Ettinger S.M.
        Gender disparities in percutaneous coronary interventions for acute myocardial infarction in Pennsylvania.
        Medical Care. 2006; 44: 24-30
        • Hu G.
        Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.
        Diabetologia. 2003; 46: 608-617
        • Institute of Medicine (IOM)
        Unequal treatment: Confronting racial and ethnic disparities in healthcare. National Academies Press, Washington, DC2003
        • Kim C.
        • Kerr E.A.
        • Bernstein S.J.
        • Krein S.L.
        Gender disparities in lipid management: The presence of disparities depends on the quality measure.
        American Journal of Managed Care. 2006; 12: 133-136
        • Legato M.J.
        Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications of therapy.
        American Journal of Cardiology. 2000; 86: 15L-18L
        • LIPID Study Group
        Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
        New England Journal of Medicine. 1998; 339: 1349-1357
        • Massey D.S.
        • Denton N.A.
        Hypersegregation in U.S. metropolitan areas: Black and Hispanic segregation along 5 dimensions.
        Demography. 1989; 26: 373-391
        • Massing M.W.
        • Foley K.A.
        • Carter-Edwards L.
        • Sueta C.A.
        • Alexander C.M.
        • Simpson Jr., R.J.
        Disparities in lipid management for African Americans and Caucasians with coronary artery disease: A national cross-sectional study.
        BMC Cardiovascular Disorder. 2004; 4: 15
        • Maviglia S.M.
        • Teich J.M.
        • Fiskio J.
        • Bates D.W.
        Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines.
        Journal of General Internal Medicine. 2001; 16: 531-537
        • Mehta R.N.
        • Khan I.A.
        • Mehta N.J.
        • Ryschon K.L.
        • Vasavada B.C.
        • Sacchi T.J.
        • et al.
        Age-related differences in the use of cardiac medications in patients with coronary artery disease.
        American Journal of Therapy. 2001; 8: 225-229
        • Mosca L.
        • Appel L.J.
        • Benjamin E.J.
        • Berra K.
        • Chandra-Strobos N.
        • Fabunmi R.P.
        • et al.
        Evidence-based guidelines for cardiovascular disease prevention in women.
        ArteriosclerosisThrombosisand Vascular Biology. 2004; 24: e29-e50
        • Mosca L.
        • Ferris A.
        • Fabunmi R.
        • Robertson R.M.
        Tracking women’s awareness of heart disease: An American Heart Association national study.
        Circulation. 2004; 109: 573-579
        • Mosca L.
        • Merz N.B.
        • Blumenthal R.S.
        • Cziraky M.J.
        • Fabunmi R.P.
        • Sarawate C.
        • et al.
        Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
        Circulation. 2005; 111: 488-493
      1. National Committee for Quality Assurance (NCQA). (2005). HEDIS 2005: Technical Specifications. Washington, DC: NCQA.

        • Nau D.P.
        • Ellis J.J.
        • Kline-Rogers E.M.
        • Mallya U.
        • Eagle K.A.
        • Erickson S.R.
        Gender and perceived severity of cardiac disease: evidence that women are “tougher.”.
        American Journal of Medicine. 2005; 118: 1256-1261
        • Nau D.P.
        • Mallya U.
        Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
        American Journal of Managed Care. 2005; 11: 69-73
        • Nerenz D.R.
        • Bonham V.L.
        • Green-Weir R.
        • Joseph C.
        • Gunter M.
        Eliminating racial/ethnic disparities in health care: Can health plans generate reports?.
        Health Affairs. 2002; 21: 259-263
        • Panel on DHHS Collection of Race and Ethnic Data
        Eliminating health disparities: Measurement and data needs. National Academies Press, Washington, DC2004
        • Pearson T.A.
        The under treatment of LDL-cholesterol: Addressing the challenge.
        International Journal of Cardiology. 2000; 74: S23-S28
        • Pearson T.A.
        • Laurora I.
        • Chu H.
        • Kafonek S.
        The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
        Archives of Internal Medicine. 2000; 160: 459-467
        • Persell S.D.
        • Maviglia S.M.
        • Bates D.W.
        • Ayanian J.Z.
        Ambulatory hypercholesterolemia management in patients with atherosclerosis.
        Journal of General Internal Medicine. 2005; 20: 123-130
        • Phillips L.S.
        • Ziemer D.C.
        • Doyle J.P.
        • Barnes C.S.
        • Kolm P.
        • Branch W.T.
        • et al.
        An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: Improving primary care of African Americans with diabetes (IPCAAD) 7.
        Diabetes Care. 2005; 28: 2352-2360
        • Pinn V.W.
        Sex and gender factors in medical studies: implications for health and clinical practice.
        Journal of the American Medical Association. 2003; 289: 397-400
        • Qureshi A.I.
        • Suri M.F.
        • Guterman L.R.
        • Hopkins L.N.
        Ineffective secondary prevention in survivors of cardiovascular events in the US population: Report from the Third National Health and Nutrition Examination Survey.
        Archives of Internal Medicine. 2001; 161: 1621-1628
        • Raudenbush S.W.
        • Bryk A.S.
        Hierarchical linear models: Applications and data analysis methods. Sage, Thousand Oaks, CA2001
        • Schulman K.A.
        • Berlin J.A.
        • Harless W.
        • Kerner J.F.
        • Sistrunk S.
        • Gersh B.J.
        • et al.
        The effect of race and sex on physicians’ recommendations for cardiac catheterization.
        New England Journal of Medicine. 1999; 340: 618-626
        • Sheifer S.E.
        • Escarce J.J.
        • Schulman K.A.
        Race and sex differences in the management of coronary artery disease.
        American Heart Journal. 2000; 139: 848-857
        • Sloan K.L.
        • Sales A.E.
        • Willems J.P.
        • Every N.R.
        • Martin G.V.
        • Sun H.
        • et al.
        Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results < or = 100 mg/dl among patients who had coronary events (Northwest VA Network Study).
        American Journal of Cardiology. 2001; 88: 1143-1146
        • Smith Jr., S.C.
        What is happening in the real world in lipid therapy and is it appropriate?.
        Value Health. 1998; 1: 204-207
        • Smith Jr., S.C.
        • Allen J.
        • Blair S.N.
        • Bonow R.O.
        • Brass L.M.
        • Fonarow G.C.
        • et al.
        AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
        Journal of American College of Cardiologists. 2006; 47: 2130-2139
        • Witt B.J.
        • Roger V.L.
        Sex differences in heart disease incidence and prevalence: implications for intervention.
        Expert Opinion on Pharmacotherapy. 2003; 4: 675-683

      Biography

      Ann F. Chou, PhD, MPH, is an Assistant Professor in the Department of Health Administration and Policy at the University of Oklahoma College of Public Health and College of Medicine. She is a health services researcher whose interests focus on implementation of best practices and quality of care.

      Biography

      Sarah Hudson Scholle, MPH, DrPH, is Assistant Vice President for Research at the National Committee for Quality Assurance in Washington, DC. She is a health services researcher, and her current research focuses on quality measurement, women’s health, and disparities.

      Biography

      Carol S. Weisman, PhD, is Professor of Health Evaluation Sciences and Obstetrics and Gynecology at the Pennsylvania State University College of Medicine. She is a sociologist and health services researcher whose research focuses on women’s health, health care, and health policy.

      Biography

      Arlene S. Bierman, MD, MS, holds the Ontario Women’s Health Council Chair in Women’s Health and is Associate Professor of Medicine; Health Policy, Management and Evaluation; and Nursing at the University of Toronto and Senior Scientist at the Centre for Inner City Health Research, St. Michaels Hospital, Toronto. Her research focuses on improving quality and outcomes of care for older adults with chronic illness.

      Biography

      Rosaly Correa-de-Araujo, MD, MSc, PhD, is the Director of the Office of the Americas, Office of Global Health Affairs and a cardiovascular pathologist trained at the National Heart, Lung, and Blood Institute. Her main areas of interest include gender-based research and analysis particularly related to chronic diseases, medication use outcomes and safety, and disparities in health care.

      Biography

      Lori Mosca, MD, PhD, is Director of Preventive Cardiology at the New York-Presbyterian Hospital and Associate Professor of Medicine at Columbia University. She holds an NIH research career award in patient oriented research in applied preventive cardiology.